MedPath

SKYRIZI 360 MG SOLUCION INYECTABLE EN CARTUCHO

SKYRIZI 360 MG SOLUCION INYECTABLE EN CARTUCHO

Commercialized
Register Number

1191361005

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Dec 15, 2022

Dosage Form

SOLUCIÓN INYECTABLE EN CARTUCHO

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1191361005
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

RISANKIZUMABActive
Quantity: 360 mg
Name: RISANKIZUMAB

ATC CLASSIFICATION (3)

L04A
L04AC
L04AC18

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.